uridine has been researched along with HIV Coinfection in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geller, RJ; Morgan, BW; Santos, C | 1 |
| Bloch, M; Calmy, A; Carr, A; Cooper, DA; Delhumeau, C; Finlayson, R; Hirschel, B; Norris, R; Rafferty, M; Wand, H | 1 |
| Aberg, JA; Budhathoki, CB; Charles, S; Currier, JS; Kosmiski, L; McComsey, GA; Medvik, K; Naini, LG; Su, Z; Walker, UA | 1 |
| Balcarek, K; Beauvoit, B; Bonnet, J; Deveaud, C; Kirschner, J; Lebrecht, D; Venhoff, AC; Venhoff, N; Walker, UA | 1 |
| Andreu, A; Cano-Soldado, P; Domingo, JC; Domingo, P; Fernandez, I; Gallego-Escuredo, JM; Giralt, M; Gutierrez, Mdel M; Marti, R; Mateo, MG; Pastor-Anglada, M; Pomar, V; Torres-Torronteras, J; Vidal, F; Villarroya, F | 1 |
| Balzarini, J; Castelain, S; Duverlie, G; Fournier, C; Josse, S; Marco-Contelles, J; Moura, M; Nguyen Van Nhien, A; Postel, D; Soriano, E | 1 |
| Choi, J; Gerschenson, M; Harrill, D; Libutti, D; McComsey, GA; O'Riordan, M; Rowe, D; Storer, N | 1 |
| Koch, EC; Penning, B; Schneider, J; Walker, UA; Weis, R | 1 |
| Benesic, A; Klinker, H; Langmann, P; Schirmer, D; Walker, UA; Winzer, R; Zilly, M | 1 |
| Mascolini, M | 1 |
| Häkkinen, AM; Klinker, H; Ristola, M; Sevastianova, K; Sutinen, J; Walker, UA; Yki-Järvinen, H | 1 |
| Alter, G; Altfeld, M; Bagchi, A; Frahm, N; Hellman, J; Li, B; Meier, A; Sidhu, H; Stellbrink, HJ; Streeck, H; Teigen, N; van Lunzen, J | 1 |
| Baron, E; Lebrecht, D; McComsey, GA; O'Riordan, M; Setzer, B; Walker, UA | 1 |
| Alter, G; Altfeld, M; Brander, C; Meier, A; Streeck, H; Suscovich, TJ; Teigen, N | 1 |
| Aweeka, F; Jayewardene, AL; Lebrecht, D; Venhoff, AC; Venhoff, N; Walker, UA | 1 |
| Balzarini, J | 1 |
5 trial(s) available for uridine and HIV Coinfection
| Article | Year |
|---|---|
No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial.
Topics: Absorptiometry, Photon; Adiposity; Adult; Anti-Retroviral Agents; Anticholesteremic Agents; Dideoxynucleosides; Drug Therapy, Combination; Extremities; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lopinavir; Male; Middle Aged; Pravastatin; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Uridine | 2010 |
Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229.
Topics: Adult; CD4 Lymphocyte Count; Double-Blind Method; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Medication Adherence; Pilot Projects; Quality of Life; Uridine; Viral Load | 2010 |
Mitochondrial function, inflammation, fat and bone in HIV lipoatrophy: randomized study of uridine supplementation or switch to tenofovir.
Topics: Adenine; Adipocytes; Adipose Tissue; Adult; Anti-HIV Agents; Apoptosis; Bone Density; DNA, Mitochondrial; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Inflammation; Male; Middle Aged; Mitochondria; Organophosphonates; Reverse Transcriptase Inhibitors; RNA; RNA, Mitochondrial; Tenofovir; Uridine; Viral Load | 2012 |
Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial.
Topics: Absorptiometry, Photon; Administration, Oral; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Body Composition; Body Fat Distribution; Dietary Supplements; Double-Blind Method; Drug Administration Schedule; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Spectrum Analysis; Subcutaneous Fat; Treatment Outcome; Uridine | 2007 |
Pharmacokinetics of zidovudine and lamivudine during oral uridine supplementation with NucleomaxX.
Topics: Administration, Oral; Area Under Curve; Double-Blind Method; Female; HIV Infections; Humans; Lamivudine; Male; Placebos; Reverse Transcriptase Inhibitors; Uridine; Zidovudine | 2008 |
12 other study(ies) available for uridine and HIV Coinfection
| Article | Year |
|---|---|
The successful treatment of 5-fluorouracil (5-FU) overdose in a patient with malignancy and HIV/AIDS with uridine triacetate.
Topics: Acetates; Antimetabolites, Antineoplastic; Anus Neoplasms; Depression; Drug Overdose; Emergency Medicine; Fluorouracil; HIV Infections; Humans; Male; Middle Aged; Toxoplasmosis, Cerebral; Treatment Outcome; Uridine | 2017 |
Role of pyrimidine depletion in the mitochondrial cardiotoxicity of nucleoside analogue reverse transcriptase inhibitors.
Topics: Animals; Anti-HIV Agents; Cardiomyopathies; Cardiotoxins; Dietary Supplements; DNA Copy Number Variations; DNA, Mitochondrial; Electron Transport Complex IV; Heart; HIV Infections; Mice; Mice, Inbred BALB C; Mitochondria, Heart; Mutation; Nucleosides; Pyrimidines; Reactive Oxygen Species; Reverse Transcriptase Inhibitors; Uridine; Zalcitabine; Zidovudine | 2010 |
Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome.
Topics: Adipose Tissue; Adult; Antiretroviral Therapy, Highly Active; Female; Gene Expression; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lipids; Male; Middle Aged; Nucleoside Transport Proteins; Reverse Transcriptase Polymerase Chain Reaction; Uridine; Uridine Kinase; Uridine Phosphorylase | 2010 |
Synthesis and in vitro activity of novel N-3 acylated TSAO-T compounds against HIV-1 and HCV.
Topics: Cell Line; Chemistry Techniques, Synthetic; Hepacivirus; Hepatitis C; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Reverse Transcriptase Inhibitors; Small Molecule Libraries; Spiro Compounds; Thymidine; Uridine | 2011 |
Uridine excess does not interfere with the antiretroviral efficacy of nucleoside analogue reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cell Line; Cells, Cultured; Drug Antagonism; HeLa Cells; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Reverse Transcriptase Inhibitors; Uridine | 2003 |
Liquid chromatographic method for the determination of uridine in human serum.
Topics: Calibration; Chromatography, High Pressure Liquid; HIV Infections; Humans; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Uridine | 2004 |
Five ways to tackle toxicity (or the ant, the spider, and the bee). 6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. October 25-28, 2004, Washington, DC.
Topics: Anti-HIV Agents; Cholesterol; Drug Administration Schedule; Growth Hormone; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Lipodystrophy; Osteoporosis; Uridine | 2005 |
Side effects and complications. Uridine finally gets tested in people.
Topics: Clinical Trials as Topic; HIV Infections; Humans; Placebos; Reverse Transcriptase Inhibitors; Uridine | 2005 |
MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands.
Topics: Animals; Antigens, CD; Antiretroviral Therapy, Highly Active; Biomarkers; CD8-Positive T-Lymphocytes; Cells, Cultured; HIV Infections; HIV-1; Humans; Immune System; Interleukin-6; Ligands; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; Oligonucleotides; RNA, Viral; Toll-Like Receptors; Tumor Necrosis Factor-alpha; Uridine; Viremia | 2007 |
Uridine supplementation in HIV lipoatrophy: pilot trial on safety and effect on mitochondrial indices.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Body Composition; Body Fat Distribution; Dietary Supplements; DNA, Mitochondrial; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Pilot Projects; Safety; Subcutaneous Fat; Treatment Outcome; Uridine | 2008 |
Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells.
Topics: Cells, Cultured; Cytokines; Dendritic Cells; HIV Infections; HIV-1; Humans; Killer Cells, Natural; Ligands; Lymphocyte Activation; Lymphocyte Count; Monocytes; RNA, Viral; Toll-Like Receptor 7; Toll-Like Receptor 8; Uridine; Viremia | 2007 |
Novel concepts in the treatment of human immunodeficiency virus type 1 (HIV-1) infections by HIV-1-specific reverse transcriptase inhibitors.
Topics: Animals; Antiviral Agents; Drug Resistance; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mice; Models, Molecular; Point Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Spiro Compounds; Thymidine; Uridine | 1995 |